White & Case Advises Takeda on Agreement to Divest Select OTC and Non-Core Assets to Acino for Over U.S. $200 Million
November 06, 2019
November 06, 2019
NEW YORK, Nov. 6 -- White and Case, a law firm, issued the following news release:
Global law firm White & Case LLP has advised Takeda on the agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa (NEMEA) countries within its Growth and Emerging Markets Business Unit to Acino for a total value in excess of US$200 million.
Takeda Pharmaceutical Company Limited is a globa . . .
Global law firm White & Case LLP has advised Takeda on the agreement to divest a portfolio of select over-the-counter (OTC) and prescription pharmaceutical assets in a number of Near East, Middle East and Africa (NEMEA) countries within its Growth and Emerging Markets Business Unit to Acino for a total value in excess of US$200 million.
Takeda Pharmaceutical Company Limited is a globa . . .